Clinical trial
Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients
NCT02147600 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients
- Lead sponsor
- University Hospital, Ghent
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 9, 2014
- Completion date
- April 10, 2014
- Enrollment
- 82 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.